Evidence map›Paper›PMID 38253797›Full record

ArticleExperimental & molecular medicine2024

CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathways.

Joo-Young Im, Soo Jin Kim, Jong-Lyul Park, Tae-Hee Han, Woo-Il Kim, Inhyub Kim, Bomin Ko, So-Young Chun, Mi-Jung Kang, Bo-Kyung Kim and 8 more

Open access · goldAbstract read
In one paragraph

Article in Experimental & molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Joo-Young ImPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea. imjy@kribb.re.kr.ORCID 0000-0001-6923-8189
Soo Jin KimChungnam National University Sejong Hospital (CNUSH), Sejong, 30099, Republic of Korea.
Jong-Lyul ParkPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Tae-Hee HanBiotherapeutics Translational Research Center, KRIBB, Daejeon, 34141, Republic of Korea.
Woo-Il KimPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Inhyub KimPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Bomin KoPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
So-Young ChunPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Mi-Jung KangPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Bo-Kyung KimPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Sol A JeonPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Seon-Kyu KimPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.ORCID 0000-0002-4176-5187
Incheol RyuYD Global Life Science Co., Ltd., Seongnam-si, Gyeonggi-do, 13207, Republic of Korea.
Seon-Young KimPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.ORCID 0000-0002-1030-7730
Ki-Hoan NamLaboratory Animal Resource & Research Center, KRIBB, Cheongju, Chungbuk, Republic of Korea.
Inah HwangGraduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, 03760, Republic of Korea.
Hyun Seung BanBiotherapeutics Translational Research Center, KRIBB, Daejeon, 34141, Republic of Korea.
Misun WonPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea. misun@kribb.re.kr.
Korea Research Institute of Bioscience and Biotechnology · KRChungnam National University Hospital · KRE.ON (United Kingdom) · GBEwha Womans University · KRKorean Register (South Korea) · KRYD Global Life Science (South Korea) · KR

Funding

Korea Institute for Advancement of Technology (KIAT) TGC1262011Korea Research Institute of Bioscience and Biotechnology (KRIBB) IGM0481911Korea Research Institute of Bioscience and Biotechnology (KRIBB) KGM5192322
6 · The paper itself

Abstract

Cytochrome b5 reductase 3 (CYB5R3) is involved in various cellular metabolic processes, including fatty acid synthesis and drug metabolism. However, the role of CYB5R3 in cancer development remains poorly understood. Here, we show that CYB5R3 expression is downregulated in human lung cancer cell lines and tissues. Adenoviral overexpression of CYB5R3 suppresses lung cancer cell growth in vitro and in vivo. However, CYB5R3 deficiency promotes tumorigenesis and metastasis in mouse models. Transcriptome analysis revealed that apoptosis- and endoplasmic reticulum (ER) stress-related genes are upregulated in CYB5R3-overexpressing lung cancer cells. Metabolomic analysis revealed that CYB5R3 overexpression increased the production of nicotinamide adenine dinucleotide (NAD

Indexed as

Lung NeoplasmsProtein Serine-Threonine KinasesActivating Transcription Factor 4AnimalsApoptosisCytochrome-B(5) ReductaseEndoplasmic Reticulum StressEndoribonucleasesHumansMAP Kinase Signaling SystemMiceNADPoly(ADP-ribose) PolymerasesActivating Transcription Factor 4ATF4 protein, humanCYB5R3 protein, humanCyb5r3 protein, mouseCytochrome-B(5) ReductaseEndoribonucleasesNADPARP16 protein, humanPoly(ADP-ribose) PolymerasesProtein Serine-Threonine Kinases

Identifiers

PMID38253797
PMCPMC10834511
OpenAlexW4391108093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.